A 59-year-old man with long-term smoking presents with progressive dyspnoea. Spirometry shows FEV₁/FVC ratio 0.60 and FEV₁ 65% predicted. He has symptoms on exertion but no recent exacerbations. According to CTS COPD guidelines, what is the most appropriate initial long-acting pharmacologic therapy?